公开(公告)号：US20210032358A1

公开(公告)日：2021-02-04

申请号：US16967365

申请日：2019-02-08

Applicant: GENMAB A/S

Inventor： Jesper VALBJOERN ,  Lene Schantz HARLOW ,  Jacob Dahlqvist CLAUSEN ,  Mette Hamborg JENSEN ,  Christian CIMANDER ,  Peter Juul MADSEN

IPC: C07K16/28 ,  A61K9/00 ,  A61K47/12 ,  A61K47/26

Abstract: The present invention relates to pharmaceutical compositions and dosage unit forms of bispecific CD3xCD20 antibodies and to routes of administration.

公开(公告)号：US20220411505A1

公开(公告)日：2022-12-29

申请号：US17635258

申请日：2020-08-14

Applicant: GENMAB A/S

Inventor： Jesper VALBJOERN ,  Lene Schantz HARLOW ,  Jacob Dahlqvist CLAUSEN ,  Mette Hamborg JENSEN ,  Christian CIMANDER ,  Jesper PASS ,  Peter Juul MADSEN ,  Shan REN ,  Maria Anna Cecilia WAHLBOM ,  Bolette BJERREGAARD

IPC: C07K16/28 ,  A61P35/00

Abstract: The present invention relates to improved pharmaceutical compositions and dosage unit forms of bispecific CD3×CD20 antibodies and to routes of administration.